News
News
- Spark Therapeutics Deepens Drug Development Expertise in Hematology and Rare Disease with Appointment of Gallia G. Levy, M.D., Ph.D., as Chief Medical Officer
08/10/2020 / 13:30 - GlobeNewswire - Merus Announces Financial Results for the Second Quarter and Provides Business Update
08/06/2020 / 22:07 - GlobeNewswire - Prothena Reports Second Quarter 2020 Financial Results and Provides R&D Update
08/06/2020 / 22:05 - GlobeNewswire - Sarepta Therapeutics Announces Second Quarter 2020 Financial Results and Recent Corporate Developments
08/05/2020 / 22:05 - GlobeNewswire - Spark Therapeutics Recognized for Fourth-straight Year as One of Philadelphia’s “Best Places to Work” by the Philadelphia Business Journal
08/03/2020 / 13:30 - GlobeNewswire - AC Immune Initiates IND-Enabling Studies for First-in-Class Antibody Targeting TDP-43 to Treat Neurodegeneration
08/03/2020 / 13:00 - GlobeNewswire - CRISPR Therapeutics to Participate in Upcoming Investor Conferences
07/30/2020 / 14:00 - GlobeNewswire - Genespire appoints Jörn Aldag as Chairman of the Board of Directors
07/30/2020 / 13:00 - GlobeNewswire - Basilea announces data presentations at ESMO Virtual Congress 2020
07/28/2020 / 07:15 - GlobeNewswire - CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial Results
07/27/2020 / 22:30 - GlobeNewswire
Real-time